Doctors in Gabon say a new single-dose malaria treatment could help curb the disease’s growing resistance to existing drugs.
Led by Dr Ghyslain Mombo-Ngoma at the Medical Research Centre of Lambaréné, researchers tested a one-time treatment combining four widely available anti-malarial compounds — sulfadoxine, pyrimethamine, artesunate and pyronaridine.
The new drug cleared malaria parasites in 93% of patients, matching the success of the standard three-day regimen.
“As malaria mortality rises, we need solutions now,” says Mombo-Ngoma. “So we thought, why not make the most of existing anti-malarial drugs.”
For many Gabonese, malaria remains a constant struggle. Libreville resident Julicia Nfono says the disease keeps coming back despite preventive measures.
“Even though we use mosquito nets and protect ourselves from dirty water, as long as there are mosquitoes, it always comes back,” she says.
According to Gabon’s National Malaria Control Programme, the country recorded more than 154 000 cases in 2024, with children under five most affected.
Programme official Hugues Ngomo calls malaria “a major public health problem.”
The single-dose approach could help improve treatment compliance, reduce resistance and make malaria care more accessible in Africa’s most affected communities.
– Africa News
In an age of information overload, Sunrise is The Namibian’s morning briefing, delivered at 6h00 from Monday to Friday. It offers a curated rundown of the most important stories from the past 24 hours – occasionally with a light, witty touch. It’s an essential way to stay informed. Subscribe and join our newsletter community.
The Namibian uses AI tools to assist with improved quality, accuracy and efficiency, while maintaining editorial oversight and journalistic integrity.
Stay informed with The Namibian – your source for credible journalism. Get in-depth reporting and opinions for
only N$85 a month. Invest in journalism, invest in democracy –
Subscribe Now!
